UnitedHealth Group (NYSE:UNH) Price Target Raised to $400.00

UnitedHealth Group (NYSE:UNHFree Report) had its target price raised by KeyCorp from $350.00 to $400.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an overweight rating on the healthcare conglomerate’s stock.

Several other equities analysts have also recently commented on the stock. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Barclays increased their target price on UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Piper Sandler reduced their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Hold” and an average target price of $383.09.

View Our Latest Stock Analysis on UNH

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $354.30 on Wednesday. The stock has a market cap of $320.88 billion, a P/E ratio of 15.35, a price-to-earnings-growth ratio of 2.38 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a 50 day moving average of $318.21 and a 200-day moving average of $350.41. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter last year, the company posted $6.80 earnings per share. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. Net Worth Advisory Group raised its position in shares of UnitedHealth Group by 0.6% during the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock worth $1,907,000 after buying an additional 21 shares in the last quarter. Bensler LLC raised its holdings in UnitedHealth Group by 0.3% during the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock worth $3,637,000 after purchasing an additional 22 shares in the last quarter. Lakeridge Wealth Management LLC raised its holdings in UnitedHealth Group by 5.8% during the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock worth $220,000 after purchasing an additional 23 shares in the last quarter. Nabity Jensen Investment Management Inc raised its stake in shares of UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,446,000 after buying an additional 24 shares in the last quarter. Finally, BigSur Wealth Management LLC raised its stake in shares of UnitedHealth Group by 0.5% in the 1st quarter. BigSur Wealth Management LLC now owns 4,743 shares of the healthcare conglomerate’s stock worth $2,484,000 after buying an additional 25 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.